Showing results (1-10 of 39) with videos related to
Sort By:
Pageof 4
Biochimica Et Biophysica Acta|May 1, 2007
TRP channels and painDaniel N Cortright, James E Krause, Daniel C BroomExpert Opinion on Drug Discovery|March 20, 2013
New frontiers in assessing pain and analgesia in laboratory animalsDaniel N Cortright, David J Matson, Daniel C BroomMethods in Molecular Biology (Clifton, N.J.)|March 26, 2010
Locomotor activity in a novel environment as a test of inflammatory pain in ratsDavid J Matson, Daniel C Broom, Daniel N CortrightCurrent Opinion in Investigational Drugs (London, England : 2000)|January 29, 2005
Transient receptor potential ion channels as targets for the discovery of pain therapeuticsJames E Krause, Bertrand L Chenard, Daniel N CortrightThe Journal of Pharmacology and Experimental Therapeutics|October 20, 2006
Inflammation-induced reduction of spontaneous activity by adjuvant: A novel model to study the effect of analgesics in ratsDavid J Matson, Daniel C Broom, Susan R Carson, et al.Current Eye Research|January 28, 2009
C5a, but not C3a, increases VEGF secretion in ARPE-19 human retinal pigment epithelial cellsDaniel N Cortright, Robin Meade, Stephen M Waters, et al.The Journal of Pharmacology and Experimental Therapeutics|September 6, 2008
Characterization of N-(adamantan-1-ylmethyl)-5-[(3R-amino-pyrrolidin-1-yl)methyl]-2-chloro-benzamide, a P2X7 antagonist in animal models of pain and inflammationDaniel C Broom, David J Matson, Elizabeth Bradshaw, et al.The Annals of Thoracic Surgery|December 23, 2006
Leukocyte effects of C5a-receptor blockade during simulated extracorporeal circulationChristine S Rinder, Michael J Smith, Henry M Rinder, et al.European Journal of Biochemistry|May 7, 2004
Biochemical pharmacology of the vanilloid receptor TRPV1. An updateDaniel N Cortright, Arpad SzallasiPageof 4